Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization<sup>â</sup>.

Qian, Xia; Zhang, Wei; Shams, Alireza; Mohammed, Kahee; Befeler, Alex S; Kang, Ningling; Lai, Jinping

Yes-associated protein-1 may serve as a diagnostic marker and therapeutic target for residual/recurrent hepatocellular carcinoma post-transarterial chemoembolization^â.

Qian, Xia; Zhang, Wei; Shams, Alireza; Mohammed, Kahee; Befeler, Alex S; Kang, Ningling; Lai, Jinping.

Afiliação

Qian X; Department of Pathology, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Zhang W; Division of Gastroenterology, Hepatology and Nutrition, Department of Medicine, University of Florida, Gainesville, FL, USA.
Shams A; Department of Pathology, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Mohammed K; Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Befeler AS; Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, Saint Louis, MO, USA.
Kang N; The Hormel Institute, University of Minnesota and Mayo Clinic, Austin, MN, USA.
Lai J; Department of Pathology, Saint Louis University School of Medicine, Saint Louis, MO, USA.

Liver Res ; 4(4): 212-217, 2020 Dec.

Article em En | MEDLINE | ID: mdl-33520338

Palavras-chave

Cancer stem cell (CSC); Hepatoblastoma; Immunohistochemistry; Residual/recurrent hepatocellular; Transarterial chemoembolization (TACE); Yes-associated protein-1 (YAP1); carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Risk_factors_studies Idioma: En Revista: Liver Res Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google